Company Filing History:
Years Active: 2015
Title: Constantin Pournaras: Innovator in Monoclonal Antibody Formulations
Introduction
Constantin Pournaras is a notable inventor based in Conches, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the development of innovative formulations for monoclonal antibodies.
Latest Patents
Pournaras holds a patent for "Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs." This invention focuses on combination formulations of monoclonal antibodies with anti-inflammatory agents, along with related methods and uses. His work aims to enhance the efficacy and stability of these important therapeutic agents.
Career Highlights
Currently, Constantin Pournaras is affiliated with the University of Geneva. His research and inventions have positioned him as a key figure in the advancement of medical treatments involving monoclonal antibodies.
Collaborations
Pournaras has collaborated with esteemed colleagues, including Robert Gurny and Cinzia Stella. Their joint efforts have contributed to the development of innovative solutions in the field of pharmaceuticals.
Conclusion
Constantin Pournaras is a distinguished inventor whose work in monoclonal antibody formulations has the potential to significantly impact medical treatments. His contributions reflect a commitment to advancing healthcare through innovation.